Impact of the CYP2D6 phenotype on hyperprolactinemia development as an adverse event of treatment with atypical antipsychotic agents in pediatric patients

ConclusionsFor the slow and intermediate metabolizers, atypical antipsychotics determined a significant increase of prolactinemia with high risk of adverse events.

Source: Irish Journal of Medical Science - February 15, 2019 Category: General Medicine Source Type: research